Form D · Biotechnology

BIOSTRATUM INC

Raleigh, NC · CIK 0000933735

Offering snapshot reported Nov 29, 2011 · SEC filing

Reported sold
$600K
Offering amount: $600K
Investors reported
24
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 19, 2011
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$300K$600KSep 6, 2011: $306,010.00Sep 6, 2011Nov 29, 2011: $599,999.00Nov 29, 2011

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$306,010 → $599,999
  • Reported investors6 → 24

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 29, 2011Amendment$599,999$293,989vs Sep 6, 201124SEC filing
Sep 6, 2011Initial$306,010No comparison6SEC filing
Jan 18, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-165401

Source: Form D, filed Nov 29, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Eggert Dagbjartsson Director
Birgir O. Haraldsson Director
John B. Mazur Director
Per Samuelsson Director
Eugen Steiner Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
C/O Wyrick Robbins Yates & Ponton Llp 4101 Lake Boone Trail Suite 300
Raleigh, NC, 27607